Boston Partners
- SEC CIK
- 0001386060
- Latest filing
- Aug 4, 2026
VVOS holding history
Vivos Therapeutics, Inc. in every 13F filed by Boston Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VVOS overviewAll 13F holders of VVOSFull Q2 2026 holdings
- Shares (Q4 2022)
- 0
- Sold out in Q4 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2022 | 0 | $0 | 0.0% | −78,454−100.0% | Sold out | Holders |
| Q3 2022 | 78,454 | $51.0K | <0.1% | −45,688−36.8% | Reduced | Holders |
| Q2 2022 | 124,142 | $160.0K | <0.1% | −13,212−9.6% | Reduced | Holders |
| Q1 2022 | 137,354 | $368.0K | <0.1% | +29,339+27.2% | Added | Holders |
| Q4 2021 | 108,015 | $243.0K | <0.1% | +61,364+131.5% | Added | Holders |
| Q3 2021 | 46,651 | $188.0K | <0.1% | +46,651 | New | Holders |